Pfizer (PFE)

$35.70 0.06 (0.17%)

12:51 EDT PFE Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 208.83B

PE Ratio 9.92

EPS 3.6

Volume (Avg. Vol.) 5.63M

Day's Range 35.52 - 35.89

52-Week Range 27.88 - 40.97

Dividend & Yield 1.36 (3.81%)

PFE Stock Predictions, Articles, and Pfizer News

From InvestorPlace
From the Web

Pfizer Shares May Catch Momentum Soon From Vaccine Work

By Tezcan Gecgil, InvestorPlace Contributor Sep 22, 2020

PFE's dividend yield as well as prospects for a Covid-19 vaccine should put Pfizer stock on the radar of long-term investors.

Pfizer Is Your Best Bet at a Covid-19 Vaccine Play

By Muslim Farooque Sep 22, 2020

Expect Pfizer to skyrocket come October as it attempts to produce a vaccine for the novel coronavirus in record time. PFE stock is a buy.

Buy JetBlue Stock at These Levels and Sock It Away for the Recovery

By Ian Cooper Sep 21, 2020

While airlines are still plenty of volatility, I’d use the weakness to pick up "blood in the street" opportunities like JBLU stock.

Profit From Pfizer Stock as It Surges on Big Vaccine Hopes

By Tyler Craig, Tales of a Technician Sep 15, 2020

Pfizer stock kicked off the week with a big bang and coronavirus vaccine hopes. Here is how to profit from PFE right here.

Pfizer Stock Pops on Vaccine Timeline News, Trial Expansion

By Sarah Smith, InvestorPlace Web Content Producer Sep 14, 2020

Pfizer stock and partner BioNTech are rallying Monday morning on news the two companies could vaccinate Americans before the end of 2020.

3 High Dividend Stocks to Buy and Hold

By Divya Premkumar, InvestorPlace Contributor Sep 9, 2020

In a volatile economy, investors use a high dividend yield as a benchmark for buying stocks. Here are top dividend stocks to buy right now.

Compare Brokers

Pfizer Stock Will Soar With Its First-Mover Vaccine Advantage

By Mark R. Hake, CFA Sep 3, 2020

Pfizer will have first-mover advantage with its Covid-19 vaccine. But that is not the only reason to be bullish on PFE stock.

This Company is the Landlord of Life Sciences

By Neil George, Editor, Profitable Investing Aug 7, 2020

Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.

5 Biotech Stocks That Offer Long-Term Growth and Value

By Faizan Farooque Aug 6, 2020

Biotech stocks are on fire at the moment. That said, here are five names from the sector that offer long-term value and strong fundamentals.

4 Coronavirus Stocks to Buy as the Pandemic Rages On

By Faisal Humayun Aug 3, 2020

As the pandemic continues to grow, these four coronavirus stocks are great ways to protect your portfolio for the foreseeable future.

4 Safe Stocks You Can Put in a Drawer

By Faisal Humayun Jul 28, 2020

Safe stocks have a low beta coupled with strong fundamentals, robust cash flows and an attractive dividend.

4 Top Stock Trades for Tuesday: MCD, DKNG, PFE, HAS

By Bret Kenwell, InvestorPlace Contributor Jul 27, 2020

Let's dial up some earnings previews on Pfizer and McDonald's, and take a look at DraftKings and Hasbro as our top stock trades.

Compare Brokers

5 High-Yield Drug Stocks That Are Undervalued With Great Upside

By Mark R. Hake, CFA Jul 24, 2020

As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.

4 Top Stock Trades for Thursday: AMD, MSFT, PFE, WORK

By Bret Kenwell, InvestorPlace Contributor Jul 22, 2020

AMD, Microsoft, Pfizer and Slack were our top stock trades from Wednesday. So, here's how the charts are looking now with earnings in play.

The 7 Best Dividend-Paying Stocks for Cautious Investors

By Tezcan Gecgil, InvestorPlace Contributor Jul 10, 2020

Market volatility is increasing. Here are seven robust companies whose shares are possibly among the best dividend-paying stocks for cautious investors

4 Pharmaceutical Stocks to Watch for the Rest of 2020

By Faisal Humayun Jul 7, 2020

As pharmaceutical companies rush to manufacture coronavirus vaccine and drugs, it makes sense to hold some potential winners.

Pfizer Stock Is a Reliable Workhorse Among Headline Hogs

By Nicolas Chahine, InvestorPlace Contributor Jul 7, 2020

PFE stock is not that exciting, but it is on solid ground. Furthermore, the company is on the verge of a breakout on the Covid-19 front.

5 Top Stock Trades for Thursday: ROKU, SHOP, RNG, PFE, FDX

By Bret Kenwell, InvestorPlace Contributor Jul 1, 2020

Shopify, Roku, RingCentral, Pfizer and FedEx were our top stock trades from Wednesday. So, let's look at the charts as we turn to Thursday.

Compare Brokers

Pfizer News: PFE Stock Surges 4% on Positive Covid-19 Vaccine Results

By William White, InvestorPlace Writer Jul 1, 2020

Pfizer (PFE) news for Wednesday concerning one of its vaccines designed to treat the novel coronavirus has PFE stock taking off.

How to Play the Downtrend in PFE Stock

By Tyler Craig, Tales of a Technician Jun 29, 2020

The healthcare sector is meandering and PFE stock is a laggard. Abandon bull trade ideas and embrace bearish ones.

More than 30 biotech and pharmaceutical companies are racing to develop a safe Covid-19 vaccine. Several candidates entered late stage trials in a matter of months. Two of the companies developing a vaccine — Pfizer and Moderna — are utilizing a promising new technology using messenger RNA. Watch the video to learn why experts believe this vaccination method could be a game changer for getting back to normal.

FDA issues final rule for importation of drugs from abroad (NYSE:PFE)

From Seeking Alpha Sep 25, 2020

Following through on President Trump's Executive Order in July aimed at cutting U.S. drug costs via importation, the FDA issues its final rule on allowing agency-authorized programs to import medicines, including biologics, from Canada under certain conditions that ensure safety.The guidance describes procedures drug makers can follow, including obtaining a National Drug Code (NDC), to facilitate the importation of prescription drugs and biologics that are FDA-approved, manufactured abroad, authorized for sale in any foreign country and originally intended for sale in that foreign country.The rule allows states (including the District of Columbia and territories), Indian tribes and — in certain future circumstances — pharmacists and wholesalers, to submit importation program proposals to the FDA for review and authorization.

Smokeless Tobacco Treatment Market May See a Big Move : Novartis, Cigna, Yesmoke

From SBWire Sep 24, 2020

Edison, NJ -- (SBWIRE) -- 09/24/2020 -- Global Smokeless Tobacco Treatment Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Smokeless Tobacco Treatment Market. Some of the key players profiled in the study are Pfizer Inc. (United States), GlaxoSmithKline plc. (United Kingdom), Johnson & Johnson Services Inc. (United States), Novartis (Switzerland), Cigna (United States), Yesmoke (Italy), Habitrol (New Zealand), Perrigo Co. Plc. (Ireland) and Cambrex Corporation (United States).

Personalized Medicine Market Set to Witness Surge in Demand over the Forecast Period of 2017-2025

From SBWire Sep 25, 2020

Albany, NY -- (SBWIRE) -- 09/25/2020 -- Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine. In personalized medicine, diagnostic analysis is often conducted for selecting suitable and best treatments based on the patient's genetic content or other molecular or cellular analysis. Personalized medicine has best response and highest safety margin to ensure enhanced patient care by allowing every patient to attain earlier diagnosis, risk assessment, and best treatment. Additionally, personalized medicine offers opportunities to improve health care by lowering overall treatment costs.

Navellier Ratings

Total Grade

Hold

Pfizer (PFE)

PFE Stock Predictions, Articles, and Pfizer News

Navellier Ratings

Total Grade

Subscriber Sign in